ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1552

Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients

Susan J. Bartlett1, Olufemi Adelowo2, Maria Celia Bazan Bardales3 and Ines Colmegna4, 1Medicine , Divisions of Clinical Epidemiology, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 2Rheumatology, Arthrimed Specialist Clinic, Lagos, Nigeria, 3Rheumatology, McGill University, Montreal, QC, Canada, 4McGill University, Montreal, QC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Illness perceptions (IP) are the beliefs and expectations that an individual has about medical conditions. IP cluster around five coherent themes and provide a framework for patients to make sense of their symptoms, assess health risk, and direct action and coping. Positive IPs have been associated with higher adherence, better disease outcomes and wellbeing in several chronic diseases while addressing negative or incorrect perceptions has been shown to improve disease outcomes. We explored IP of Canadian and Nigerian RA patients. 

Methods: Consecutive RA patients at two academic centers (Montreal and Lagos) completed the Illness Perception Questionnaire–Revised from 2013-14. Sociodemographic (age, sex, and education) and disease characteristics (duration, treatment, CDAI, HAQ) were obtained and compared  with t-tests and chi-square, Spearman correlations were calculated between IPQ-R scales and CDAI levels and t-tests and ANOVA were used to compare IPQ scores between countries and across disease activity levels.

Results: 83 Canadian and 30 Nigerian patients completed the survey. While there were no significant differences in the age, sex and education  or use of biologics between groups, African participants reported shorter disease duration and had higher CDAI  and patient global scores (Table 1). In Canadians, Timeline-Cyclic, Consequences, and Treatment Control were associated with CDAI (rho’s=.28 to -.40; p<.05) whereas in Nigerians, Emotional Representations were moderately associated with CDAI (rho=.40; p<.05)(Table 2). Scores on Timeline – Chronic and Illness Coherence were significantly (p<.05) higher in Canadians whereas Treatment Control scores were significantly higher in Nigerians. Beliefs about causes of RA were similar in patients from both countries, although ‘chance’ or ‘other factors’ were cited by Nigerians.

Conclusion: Canadians were more likely to view their arthritis symptoms as coherent and chronic whereas Nigerians were more likely to view their RA as controllable through treatments but resulting in greater emotional distress. Understanding illness perceptions, beliefs about aetiology, and expectations about controllability may offer new insight into patient behaviors (e.g., adherence to treatment) that impact long-term outcomes.

Table 1. Characteristics of Participants in Canada and Nigeria

Characteristic

Canada

Nigeria

Sig

N

83

30

 

Age (yrs)

 

 

.583

    18-29

6 (7%)

2 (7%)

 

    30-49

34 (45%)

16 (53%)

 

    50-69

31 (37%)

10 (33%)

 

    70+

12 (14%)

2 (7%)

 

Female (%)

66 (80%)

24 (83%)

.705

Education (yrs)

15 (4)

16 (5)

.607

RA duration (yr)

 

 

.018

    < 1

13 (16%)

13 (43%)

 

    1-5

32 (39%)

6 (20%)

 

    5-10

18 (22%)

5 (17%)

 

    10+

20 (24%)

6 (20%)

 

Biologics (ever)

23 (28%)

4 (14%0

.117

HAQ

.55 (.64)

N/A

 

Tender (28)

3.5 (4.5)

6.5 (7.4)

.013

Swollen (28)

2.3 (3.7)

3.9 (5.8)

.086

Patient Global

2.7 (2.4)

3.8 (2.3)

.027

CDAI

10.4 (10.2)

17.4 (13.9)

.005

     Remission

22 (27%)

1 (3%)

.017

     Low

29 (35%)

11 (38%)

 

     Moderate

22 (27%)

8 (28%)

 

     High

10 (14%)

9 (31%)

 

Values are mean ± SD unless otherwise indicated

 

Table 2. Association of IPQ Scales with CDAI and mean scores by disease activity level.

IPQ-R Subscale (range)

CDAI (rho)

All

Remission

Low

Moderate

High

CAN

NIG

CAN

NIG

CAN

N=22

NIG

N=1

CAN

N=29

NIG

N=11

CAN

N=22

NIG

N=11

CAN

N=10

NIG

N=9

Identity

.08

.59

5 (2)

7 (3)

5 (3)

—

5 (3)

5 (1)

6 (2)

4 (1)

6 (2)

9 (3)

Timeline  Chronic (6-30)

.17

-.21

23 (5)

14 (6)*

22 (6)

18

22 (6)

14 (7)

24 (4)

15 (5)

23 (5)

12 (7)

             – Cyclical (4-20)

.38

-.02

13 (3)

12 (4)

12 (4)a

16

13 (4)a,b

11 (4)

14 (3)b

12 (4)

15 (2) b,c

12 (3)

Consequences (6-30)

.28

.38

20 (5)

21 (5)

18 (5)a

19

19 (5)a

18 (5)

20 (4)a,b

23 (3)

23 (4)b

23 (5)

Control – Treatment (5-25)

-.40

.06

19 (3)

21 (3)*

20 (3)a

14

18 (3)b

21 (4)

18 (3)b

20 (2)

18 (2)b

22 (3)

            — Personal (6-30)

-.13

.20

22 (4)

22 (6)

23 (4)

18

21 (3)

21 (5)

21 (4)

23 (4)

22 (4)

21 (8)

Understanding of RA (5-25)

-.09

-.17

18 (4)

16 (5)*

18 (5)

11

18 (4)

18 (5)

18 (4)

15 (4)

16 (4)

15 (6)

Emotional Response (6-30)

.15

.40

17 (6)

19 (7)†

15 (6)

7

17 (5)

16 (6)a

16 (6)

20 (7)a,b

18 (6)

22 (5)b

*p<.05; †p=.07. Different superscripts indicate significant different groups using Duncan’s tests.

Table 3. Participant rankings of top three causes of RA by country.

 

Canada

Nigeria

Risk Factors (genetics, diet, aging, smoking, previous medical care)

40 (48%)

12 (40%)

Altered Immunity (germs/virus, pollution, changes in immunity)

17 (21%)

6 (20%)

Psychological Factors (stress, negative emotions, overwork

14 (17%)

5 (17%)

Don’t Know

9 (11%)

2 (7%)

Accident / chance

3 (4%)

2 (7%)

Other (spiritual, cold, drug reaction)

—

3 (10%)

chi square .091


Disclosure: S. J. Bartlett, PCORI, 2,NIH, 9; O. Adelowo, None; M. C. Bazan Bardales, None; I. Colmegna, None.

To cite this abstract in AMA style:

Bartlett SJ, Adelowo O, Bazan Bardales MC, Colmegna I. Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/illness-perceptions-in-rheumatoid-arthritis-a-comparison-of-canadian-and-nigerian-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/illness-perceptions-in-rheumatoid-arthritis-a-comparison-of-canadian-and-nigerian-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology